Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 10/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | MAOB | P27338 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | BCHE | P06276 | 2/20 | 1.00 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 1.00 |
| ▸ | PLIN1 | O60240 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 1.00 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.78 |
| ▸ | HSPD1 | P10809 | 3/20 | 0.78 |
| ▸ | HSPE1 | P61604 | 3/20 | 0.78 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.78 |
| ▸ | RAB9A | P51151 | 2/20 | 0.78 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.78 |
| ▸ | RELA | Q04206 | 2/20 | 0.78 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chalcone SCHEMBL29922932 | 1.00 | CYP1B1 (1.00) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL27580 | 1.00 | CYP1B1 (1.00) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL28306720 | 1.00 | CYP1B1 (1.00) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL27581 | 1.00 | CYP1B1 (1.00) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL29396001 | 1.00 | CYP1B1 (1.00) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL2404758 | 1.00 | CYP1B1 (1.00) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL2427445 | 0.98 | CYP1B1 (0.96) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL527181 | 0.98 | CYP1B1 (0.96) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL7861207 | 0.98 | CYP1B1 (0.96) | CYP1B1MAPTMAOBLMNABCHE | |
| Chalcone SCHEMBL7653806 | 0.98 | CYP1B1 (0.96) | CYP1B1MAPTMAOBLMNABCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3164196-B1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TOPGENIX INC (US) | 2021-08-18 | — | — | EP | claimed |
| EP-2859069-B1 | METHOD AND APPARATUS FOR TREATING PETROLEUM EQUIPMENT | FERRARA MARCELLO (IT) | 2020-10-14 | — | — | EP | claimed |
| EP-2025324-B1 | Method of Quenching Electronic Excitation of Chromophore-Containing Organic Molecules in Photoactive Compositions | HALLSTAR INNOVATIONS CORP (US) | 2013-08-14 | — | — | EP | claimed |
| EP-1187865-B1 | METHOD FOR PRODUCING OF MATRESSES, UPHOLSTERIES FOR FURNITURE OR CARPET BACKINGS | BASF AG (DE) | 2005-11-09 | — | — | EP | claimed |
| EP-0973636-B1 | TRANSPARENT ARTICLE WITH RADIAL REFRACTIVE INDEX GRADIENT AND PROCESS FOR ITS MANUFACTURE | ESSILOR INT (FR) | 2003-01-02 | — | — | EP | claimed |
| EP-0177122-B1 | ACRYLAMIDE DERIVATIVES | Nippon Paint Co., Ltd. (JP) | 1992-04-01 | — | — | EP | claimed |
| EP-0262672-B1 | NON-LINEAR OPTICAL ARTICLE | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1991-11-27 | — | — | EP | claimed |
| JP-10026760-A | — | — | None | — | — | JP | disclosed |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12252642-B2 | Method for producing cholesteric liquid crystal layer, cholesteric liquid crystal layer, optically anisotropic body, and reflective film | FUJIFILM CORPORATION (JP) | 2025-03-18 | — | — | US | disclosed |
| WO-2024247969-A1 | DECORATIVE FILM, DISPLAY DEVICE, AND AUTOMOBILE INTERIOR FINISHING | 富士フイルム株式会社 | 2024-12-05 | — | — | WO | disclosed |
| US-20230026978-A1 | PHOTOISOMERIZED COMPOSITIONS OF ANTHOCYANINS AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2023-01-26 | — | — | US | disclosed |
| US-20220204850-A1 | METHOD FOR PRODUCING CHOLESTERIC LIQUID CRYSTAL LAYER, CHOLESTERIC LIQUID CRYSTAL LAYER, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM | FUJIFILM CORPORATION (JP) | 2022-06-30 | — | — | US | disclosed |
| WO-1994007889-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1994-04-14 | — | — | WO | disclosed |
| US-5274132-A | Photochromic naphthopyran compounds | TRANSITIONS OPTICAL, INC. (US) | 1993-12-28 | — | — | US | disclosed |
| EP-0489778-A1 | ANTI-INFLAMMATORY ACTIVE INGREDIENTS FOR COSMETIC PREPARATIONS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1992-06-17 | — | — | EP | disclosed |
| WO-1991003232-A1 | ANTI-INFLAMMATORY ACTIVE INGREDIENTS FOR COSMETIC PREPARATIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1991-03-21 | — | — | WO | disclosed |
| WO-1991002515-A1 | ANTI-INFLAMMATORY SUBSTANCES FOR COSMETIC PREPARATION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1991-03-07 | — | — | WO | disclosed |
| WO-1991002514-A1 | ANTI-INFLAMMATORY ACTIVE SUBSTANCES FOR COSMETIC COMPOSITIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1991-03-07 | — | — | WO | disclosed |
| EP-0233455-A1 | Hydrogenation and reduction by means of the hydrocarbon/carbon system | BASF Aktiengesellschaft (DE) | 1987-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | CYP1B1 230/4885MAPT 3297/4885MAOB 1004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.